A Phase II, Randomised, Single-Blind, Platform Trial To Assess Safety, Reactogenicity And Immunogenicity Of COVID-19 Vaccines In Pregnant Women In The United Kingdom
This study aims to recruit, vaccinate and follow-up pregnant women across the UK in order to look at the safety of, and immune responses to, COVID-19 vaccines in pregnant women and their babies.